KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Interest Coverage Ratio (2018 - 2025)

TherapeuticsMD (TXMD) has disclosed Interest Coverage Ratio for 12 consecutive years, with 287.33 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Coverage Ratio rose 23.99% year-over-year to 287.33, compared with a TTM value of 303.29 through Sep 2025, up 86.37%, and an annual FY2021 reading of 2.42, up 55.58% over the prior year.
  • Interest Coverage Ratio was 287.33 for Q3 2025 at TherapeuticsMD, up from 347.5 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 3.27 in Q4 2021 and bottomed at 435.5 in Q1 2025.
  • Average Interest Coverage Ratio over 5 years is 138.0, with a median of 54.14 recorded in 2023.
  • The sharpest move saw Interest Coverage Ratio soared 172.01% in 2021, then crashed 4200.62% in 2023.
  • Year by year, Interest Coverage Ratio stood at 3.27 in 2021, then tumbled by 137.89% to 1.24 in 2022, then crashed by 7047.55% to 88.65 in 2023, then tumbled by 326.4% to 378.0 in 2024, then rose by 23.99% to 287.33 in 2025.
  • Business Quant data shows Interest Coverage Ratio for TXMD at 287.33 in Q3 2025, 347.5 in Q2 2025, and 435.5 in Q1 2025.